There’s been a lot of good news last week, and I tweeted some of it. A lot of private sector companies are stepping up to manufacture the tools needed to defeat the Chinese Wuhan virus. They’re making hand sanitizer, respirator masks, ventilators, and even prescription drugs for testing and treatment. One company really stood out to me, though, so let’s read about them first.
Daily Wire reported:
Novartis Chief Executive Vas Narasimhan said Sunday that the Trump-touted drudged hydroxychloroquine, often used to treat malaria, is our biggest hope in combating the China-originated coronavirus, or COVID-19.
Narasimhan pledged to donate a stunning 130 million doses of hydroxychloroquine and will support studies of the drug as a treatment against COVID-19.
Novartis Chief Executive Vas Narasimhan said his Sandoz generics unit’s malaria, lupus and arthritis drug hydroxychloroquine is the company’s biggest hope against the coronavirus, Swiss newspaper SonntagsZeitung reported on Sunday.
Novartis has pledged to donate 130 million doses and is supporting clinical trials needed before the medicine, which U.S. President Donald Trump also has been promoting, can be approved for use against the coronavirus.
“Pre-clinical studies in animals as well as the first data from clinical studies show that hydroxychloroquine kills the coronavirus,” Narasimhan told Swiss newspaper SonntagsZeitung. “We’re working with Swiss hospitals on possible treatment protocols for the clinical use of the drug, but it’s too early to say anything definitively.”
According to Reuters, pharmaceutical companies Bayer and Teva “have also agreed to donate hydroxychloroquine or similar drugs, while Gilead Sciences is testing its experimental drug remdesivir against coronavirus.”
As noted by The Daily Wire on Sunday, France officially sanctioned this weekend chloroquine for certain patients infected with COVID-19.
“The French government has officially sanctioned prescriptions of chloroquine to treat certain coronavirus patients,” France 24 English reported Saturday.
“This ensures continued treatment of patients who have been treated for several years for a chronic condition with this drug, but also allows a temporary authorization to allow certain patients with coronavirus to benefit from this therapeutic route,” said Jérôme Salomon, France’s director general of health.
According to a report from Trustnodes, France’s move comes after infectious disease specialist Didier Raoult announced new clinical results… that show 78 out of 80 patients treated with chloroquine recovered within five days.
Trump is trying to get the FDA to move quickly through testing so that these drugs can be made widely available.
The Daily Wire reported on Sunday night that the FDA is doing everything they can to get these drugs available:
On Sunday night, the Food and Drug Administration (FDA) issued an emergency use authorization for hydroxychloroquine and chloroquine, drugs often used to treat malaria and recently touted by President Donald Trump as a possible “game-changer” in the fight against the China-originated novel coronavirus, or COVID-19.
The United States Department of Health & Human Services (HHS) announced in a statement on Sunday that the FDA will allow the drugs to be “donated to the Strategic National Stockpile to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible,” a Politico report said.
The statement noted that “Sandoz donated 30 million doses of hydroxychloroquine to the stockpile and Bayer donated 1 million doses of chloroquine.”
Trump made it clear weeks ago that his administration would work to fast-track promising drugs like hydroxychloroquine with the FDA, all in an effort to combat COVID-19.
The drugs are already being tested in New York state:
Democratic New York Governor Andrew Cuomo is on the same page as President Trump when it comes to the popular anti-malaria drugs, permitting trials of hydroxychloroquine, chloroquine, and azithromycin to commence in his state.
“Let’s see how it works,” Trump said Sunday, with regard to the New York trials. “It may. It may not.”
But wait! There’s more good news.
I’m currently tracking 5 different drugs to see how they perform during tests, but here is a sixth one that I didn’t even know about.
The New York Post reports:
Two coronavirus patients in New York City are off ventilators and out of intensive care after they received an experimental drug to treat HIV and breast cancer.
[…]The drug, leronlimab, is delivered by injection twice in the abdomen, the Daily Mail reported.
Of seven critically ill patients who received the drug in New York, two were removed from ventilators and two showed significant improvement.
[…]CytoDyn, the drug’s manufacturer, could get FDA approval in six weeks if leronlimab continues to show promise. No drugs currently have FDA approval to treat the novel coronavirus.
Other private sector companies are developing faster methods to test for the Wuhan virus.
Abbott on Friday announced it received approval for a test that is capable of delivering positive results of the coronavirus in as little as five minutes, and it will begin making those tests available to health care providers next week.
The Food and Drug Administration issued emergency use authorization for the point-of-care test on Friday, the company said in a statement. The test can detect negative results in 13 minutes. The company said it plans to ramp up manufacturing so it can deliver 50,000 tests per day.
And finally, this from the Daily Wire:
Scientists studying the coronavirus have some good news: as it is transmitted through the human population, it is not undergoing significant mutations, meaning it will not become more dangerous as it spreads, and once a vaccine is developed, it could be as effective as vaccines for measles or chickenpox are. Peter Thielen, a molecular geneticist at the Johns Hopkins University Applied Physics Laboratory who is one of the scientists examining the virus, told The Washington Post,, “I would expect a vaccine for coronavirus would have a similar profile to those vaccines. It’s great news.”
So, the Trump administration is actually doing a pretty good job of cutting red tape to get people help faster. But a lot of the actual work is being down by private sector companies who are making donations and developing tests and drugs to solve the problem. Just keep that in mind when you here doom and gloom from fake news journalists and Democrat politicians.